Skip to main content
AAN.com
Articles
October 24, 2005

Multidisciplinary ALS care improves quality of life in patients with ALS

October 25, 2005 issue
65 (8) 1264-1267

Abstract

Objective: To examine the effect of multidisciplinary ALS care on the quality-of-life (QoL) in patients with ALS and their caregivers.
Methods: In a cross-sectional study, 208 patients with ALS and their caregivers were interviewed. QoL was assessed using the 36-item Short Form Health Survey (SF-36) and two visual analogue scales (VAS). Criteria for multidisciplinary ALS care were: an ALS team headed by a consultant in rehabilitation medicine and consisting of at least a physical therapist, occupational therapist, speech pathologist, dietician and a social worker; use of the Dutch ALS consensus guidelines for ALS care; and at least six incident ALS patients per year.
Results: Clinical characteristics and functional loss of the 133 patients receiving multidisciplinary ALS care and the 75 patients receiving general ALS care were similar. The percentage of patients with adequate aids and appliances was higher in those with multidisciplinary ALS care (93.1 vs 81.3%, p = 0.008), whereas the number of visits to professional caregivers was similar in both groups. Patients in the multidisciplinary ALS care group had a better mental QoL on the SF-36 Mental Summary Score than those in the general care group (p = 0.01). The difference in QoL was most pronounced in the domains of Social Functioning and Mental Health, and was independent of the presence of aids and appliances. No significant differences were found in the SF-36 Physical Summary Score, VAS, or in QoL of caregivers of patients with ALS.
Conclusion: High standard of care improves mental quality-of-life in patients with ALS.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Mitsumoto H, Del Bene M. Improving the quality of life for people with ALS: the challenge ahead. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:329–336.
2.
Van den Berg JP, Kalmijn S, Lindeman E, Wokke JHJ, van den Berg LH. Rehabilitation care for patients with ALS in the Netherlands. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:186–190.
3.
Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258–1261.
4.
Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003;209:79–85.
5.
Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology 2001;56:442–444.
6.
Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fisher S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000;55:388–392.
7.
Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003;60:122–123.
8.
Walsh SM, Bremer BA, Felgoise SH, Simmons Z. Religiousness is related to quality of life in patients with ALS. Neurology 2003;60:1527–1529.
9.
Neudert C, Wasner M, Borasio GD. Individual Quality of Life is not correlated with Health-Related Quality of Life or Physical Function in Patients with Amyotrophic Lateral Sclerosis. J Palliat Med 2004;7:551–557.
10.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 1994;124:S96–S107.
11.
Van den Berg JP, de Groot IJM, Joha BC, van Haelst JM, van Gorcom P, Kalmijn S. Development and implementation of the Dutch protocol for rehabilitative management in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:226–229.
12.
Jenkinson C, Hobart J, Chandola T, Fitpatrick R, Peto V, Swash M. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol 2002;249:178–183.
13.
Aaronson NK, Muller M, Cohen PDA, et al. Translation, validation and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055–1068.
14.
Jansen SJ, Otten W, van de Velde CJ, et al. The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life. Br J Cancer 2004;91:56–61.
15.
The ALS CNTF treatment study (ACTS) phase I-II Study Group; The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141–147.
16.
Nijs J, De Meirleir K, Duquet W. Kinesiophobia in chronic fatigue syndrome: assessment and associations with disability. Arch Phys Med Rehabil 2004;85:1586–1592.
17.
Robinson BC. Validation of a Caregiver Strain Index. J Gerontol 1983;38:344–348.
18.
Miller RG, Rosenberg JA, Gelinas DF, et al. ALS Practice Parameters Task Force: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters task Force. Neurology 1999;52:1311–1323.
19.
Chiò A, Gauthier A, Montuschi A, et al. A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry 2004;75:1597–1601.
20.
Norquist JM, Jenkinson C, Fitzpatrick R, et al. Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:112–117.
21.
Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504–509.
22.
Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989;8:142–150.

Information & Authors

Information

Published In

Neurology®
Volume 65Number 8October 25, 2005
Pages: 1264-1267
PubMed: 16247055

Publication History

Published online: October 24, 2005
Published in print: October 25, 2005

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

J. P. Van den Berg, MD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
S. Kalmijn, MD, PhD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
E. Lindeman, MD, PhD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
J. H. Veldink, MD, PhD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
M. de Visser, MD, PhD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
M. M. Van der Graaff, MD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
J.H.J. Wokke, MD, PhD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.
L. H. Van den Berg, MD, PhD
From the Departments of Neurology (Drs Van den Berg, Kalmijn, Wokke, Veldink and L.H. Van den Berg) and Rehabilitation (Dr. Lindeman), Rudolf Magnus Institute of Neuroscience, and the Julius Center for Health Sciences and Primary Care (Dr. Kalmijn), University Medical Centre Utrecht, Utrecht; the Department of Neurology (Drs. De Visser and Van der Graaff), Academic Medical Center, University of Amsterdam; and the Department of Rehabilitation (Dr. J.P. van den Berg), Meander Medical Center, Amersfoort, the Netherlands.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Sclérose latérale amyotrophique, EMC - Neurologie, 48, 1, (1-16), (2025).https://doi.org/10.1016/S0246-0378(24)44907-5
    Crossref
  2. Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study, Neurological Research and Practice, 6, 1, (2024).https://doi.org/10.1186/s42466-024-00328-1
    Crossref
  3. Exploiting Machine Learning And Gene Expression Analysis in Amyotrophic Lateral Sclerosis Diagnosis, 2024 Tenth International Conference on Communications and Electronics (ICCE), (363-368), (2024).https://doi.org/10.1109/ICCE62051.2024.10634725
    Crossref
  4. A nurse coaching intervention to improve support to individuals living with ALS, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26, 1-2, (22-28), (2024).https://doi.org/10.1080/21678421.2024.2399154
    Crossref
  5. Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25, 3-4, (282-289), (2024).https://doi.org/10.1080/21678421.2024.2304058
    Crossref
  6. The effect of social support on the emotional well-being of people with amyotrophic lateral sclerosis: Exploring the mediating role of spirituality, Palliative and Supportive Care, 22, 6, (1932-1939), (2024).https://doi.org/10.1017/S1478951524000610
    Crossref
  7. Update on recent advances in amyotrophic lateral sclerosis, Journal of Neurology, 271, 7, (4693-4723), (2024).https://doi.org/10.1007/s00415-024-12435-9
    Crossref
  8. Respiratory Care of the ALS Patient, Pulmonary Complications of Neuromuscular Disease, (243-269), (2024).https://doi.org/10.1007/978-3-031-65335-3_10
    Crossref
  9. Neuromuscular Disparities, Achieving Equity in Neurological Practice, (231-252), (2024).https://doi.org/10.1007/978-3-031-62727-9_11
    Crossref
  10. Caring for people living with ALS in Korea: challenges and possible paths forward, Muscle & Nerve, 70, 5, (881-883), (2024).https://doi.org/10.1002/mus.28241
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share